Hematology Cancer Consortium - Association - Company Profile

It is a healthcare private not for profit company based in Mumbai, Maharashtra, India, established in 2020.
2020 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Hematology Cancer Consortium - Association

Hematology Cancer Consortium - Association, a active private not for profit company, was established on 09 January 2020 in Mumbai, Maharashtra, India. Engaging in human health activities within the healthcare sector, it holds CIN: U85100MH2020NPL335745. Registered under ROC Roc Mumbai. it is unlisted.

It upholds a compliant status. Its leadership includes Vikram (Director), Palani Thyagarajan (Director), Niyati Sutaria James (Director). Past directors included Manju Sengar, Palani Thyagarajan, Niyati Sutaria James. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. 1A, Ground Floor, Deep Co-Operative Housing Society Limited, Jerbai Wadia Road, Parel Bhoiwada, Mumbai, Maharashtra, 400012.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85100MH2020NPL335745

  • Registration Number

    335745

  • Incorporation Date

    09 January 2020

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Company Age 6 Year, 24 Days
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 63.96%
  • Profit Growth **** -64.29%
  • Ebitda **** -74.59%
  • Net Worth 11.25%
  • Total Assets **** 45.35%
Company report

Hematology Cancer Consortium - Association

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hematology Cancer Consortium - Association — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Hematology Cancer Consortium - Association?
Current Directors
Name Designation Appointment Date Status
Vikram Director 09 Jan 2020 Current
Palani Thyagarajan Director 08 Dec 2021 Current
Niyati Sutaria James Director 08 Dec 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Dec 2021 Past
Pramod Abcsdd Additional Director 30 Dec 2021 Past
Pramod Abcsdd Additional Director 30 Dec 2021 Past
Pramod Abcsdd Ceo - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hematology Cancer Consortium - Association.

Hematology Cancer Consortium - Association, for the financial year ended 2023, experienced significant growth in revenue, with a 63.96% increase. The company also saw a substantial fall in profitability, with a 64.29% decrease in profit. The company's net worth Soared by an impressive increase of 11.25%.

Hematology Cancer Consortium - Association revenue growth over time
Hematology Cancer Consortium - Association profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 63.96%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 45.35%
*******
*******
*******
*******
Profit or Loss
*******
 -64.29%
*******
*******
*******
*******
Net Worth
*******
 11.25%
*******
*******
*******
*******
EBITDA
*******
 -74.59%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hematology Cancer Consortium - Association?

Unlock access to Hematology Cancer Consortium - Association's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Hematology Cancer Consortium - Association?

Unlock and access historical data on people associated with Hematology Cancer Consortium - Association, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hematology Cancer Consortium - Association, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hematology Cancer Consortium - Association's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hematology Cancer Consortium - Association
Recent Activity within the Organization
  • Annual General Meeting

    Hematology Cancer Consortium - Association last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Hematology Cancer Consortium - Association has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Palani Thyagarajan was appointed as a Director was appointed as a Director on 08 Dec 2021 & has been associated with this company since 4 years 1 month . was completed.

  • Director Appointment

    Bhavisha Sudarshan Sanadhya was appointed as a CEO was appointed as a CEO on 08 Dec 2021 & has been associated with this company since 4 years 1 month . was recorded as a recent event.

  • Director Appointment

    The activity Niyati Sutaria James was appointed as a Director was appointed as a Director on 08 Dec 2021 & has been associated with this company since 4 years 1 month . was completed.

  • Director Appointment

    The activity Vikram was appointed as a Director was appointed as a Director on 09 Jan 2020 & has been associated with this company since 6 years 24 days . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hematology Cancer Consortium - Association?

The CIN of Hematology Cancer Consortium - Association is U85100MH2020NPL335745.

Where is Hematology Cancer Consortium - Association headquartered?

Hematology Cancer Consortium - Association is headquartered at Shop No. 1A, Ground Floor, Deep Co-Operative Housing Society Limited, Jerbai Wadia Road, Parel Bhoiwada, Mumbai, Maharashtra, 400012.

When was Hematology Cancer Consortium - Association incorporated?

Hematology Cancer Consortium - Association was incorporated on 09 January 2020.

Who are the current directors of Hematology Cancer Consortium - Association?

The current directors of Hematology Cancer Consortium - Association are

What is the primary industry of Hematology Cancer Consortium - Association?

The primary industry of Hematology Cancer Consortium - Association is Healthcare.

Is Hematology Cancer Consortium - Association a listed company?

Hematology Cancer Consortium - Association is unlisted.

What is the compliance status of Hematology Cancer Consortium - Association?

The compliance status of Hematology Cancer Consortium - Association is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available